title: Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner.
abstract: One of the pathological hallmarks of Alzheimer's disease (AD) is neurofibrillary tangles (NFTs), which are composed of abnormally hyperphosphorylated tau, but the mechanism of tau hyperphosphorylation in AD is still unclear. To investigate the effects of estrogens on tau phosphorylation, SH-SY5Y cells were treated with okadaic acid (OA), a serine/threonine phosphatase inhibitor, to induce tau phosphorylation and the effects of estrogen were observed by co-treatment with 17beta-estradiol (E2). We found that OA induced in vitro tau hyperphosphorylation, which was prevented by E2 in a dose-dependent manner. This effect of E2 was partially blocked by an estrogen receptor (ER) antagonist, ICI 182,780. In addition to tau hyperphosphorylation, inhibition of serine/threonine phosphorylation induced upregulation of cdk5 levels, which was attenuated by E2 in a manner that was counteracted by ICI 182,780. Our results show that cdk5 is involved in OA-induced tau hyperphosphorylation, and estrogens ameliorate the tau hyperphosphorylation, which may be mediated in part by ER.
authors.affiliation: Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
authors.forename: Zhang
authors.initials: Z
authors.lastname: Zhang
authors.forename: James W
authors.initials: JW
authors.lastname: Simpkins
mesh_terms: D015153:Blotting, Western; D045744:Cell Line, Tumor; D051360:Cyclin-Dependent Kinase 5 / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology*; D004965:Estrogen Antagonists / Q000494:pharmacology; D004967:Estrogens / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D019319:Okadaic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D011960:Receptors, Estrogen / Q000037:antagonists & inhibitors / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects; D016875:tau Proteins / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D004965:Estrogen Antagonists; D004967:Estrogens; C054369:MAPT protein, human; D009419:Nerve Tissue Proteins; D011960:Receptors, Estrogen; C118136:TPPP protein, human; D016875:tau Proteins; D019319:Okadaic Acid; D000077267:Fulvestrant; D004958:Estradiol; D051360:Cyclin-Dependent Kinase 5; C495905:CDK5 protein, human; D010749:Phosphoprotein Phosphatases
references.citation: Trends Neurosci. 2002 Jan;25(1):22-6
references.pmid: 11801334
references.citation: FEBS Lett. 1993 Jul 5;325(3):167-72
references.pmid: 7686508
references.citation: J Biol Chem. 1987 Dec 25;262(36):17577-83
references.pmid: 3121601
references.citation: Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):347-58
references.pmid: 10817919
references.citation: Nat Rev Neurosci. 2007 Sep;8(9):663-72
references.pmid: 17684513
references.citation: Neurobiol Dis. 2004 Jun;16(1):21-8
references.pmid: 15207258
references.citation: J Neurochem. 1995 Aug;65(2):732-8
references.pmid: 7616230
references.citation: J Biol Chem. 2000 Feb 25;275(8):5535-44
references.pmid: 10681533
references.citation: Neuron. 1989 Oct;3(4):519-26
references.pmid: 2484340
references.citation: J Neurochem. 1993 Aug;61(2):673-82
references.pmid: 8336148
references.citation: Neuroscience. 1998 Aug;85(4):1337-40
references.pmid: 9681968
references.citation: J Biochem. 1986 Jun;99(6):1807-10
references.pmid: 2427509
references.citation: Biochemistry. 2004 Aug 17;43(32):10520-31
references.pmid: 15301550
references.citation: Brain Res Mol Brain Res. 2003 Oct 7;117(2):145-51
references.pmid: 14559148
references.citation: Am J Obstet Gynecol. 1997 Jan;176(1 Pt 1):1-7
references.pmid: 9024081
references.citation: Nature. 2000 May 18;405(6784):360-4
references.pmid: 10830966
references.citation: J Cell Sci. 2004 Nov 15;117(Pt 24):5721-9
references.pmid: 15537830
references.citation: Biochim Biophys Acta. 2005 Jan 3;1739(2-3):179-97
references.pmid: 15615637
references.citation: J Neurochem. 2009 Feb;108(3):732-40
references.pmid: 19054278
references.citation: Biochemistry. 2008 Aug 12;47(32):8367-77
references.pmid: 18636751
references.citation: Nat Rev Drug Discov. 2007 Jun;6(6):464-79
references.pmid: 17541419
references.citation: J Biol Chem. 1993 Nov 15;268(32):24374-84
references.pmid: 8226987
references.citation: J Biomed Biotechnol. 2006;2006(3):31825
references.pmid: 17047304
references.citation: Neurosci Lett. 1992 Nov 23;147(1):58-62
references.pmid: 1336152
references.citation: Arch Neurol. 1994 Sep;51(9):896-900
references.pmid: 8080389
references.citation: Ann N Y Acad Sci. 2005 Jun;1052:210-24
references.pmid: 16024764
references.citation: Cell Mol Life Sci. 2007 Sep;64(17):2219-33
references.pmid: 17604998
references.citation: J Neurochem. 1993 Sep;61(3):921-7
references.pmid: 8395566
references.citation: Prog Neurobiol. 2001 Nov;65(4):391-426
references.pmid: 11527574
references.citation: Cell Mol Neurobiol. 1999 Apr;19(2):249-60
references.pmid: 10081608
references.citation: Brain Res. 2010 Nov 4;1359:233-46
references.pmid: 20807517
references.citation: Proc Natl Acad Sci U S A. 1986 Jul;83(13):4913-7
references.pmid: 3088567
references.citation: Exp Biol Med (Maywood). 2006 May;231(5):514-21
references.pmid: 16636299
references.citation: Neuroreport. 2006 May 15;17(7):689-92
references.pmid: 16641670
references.citation: Front Neuroendocrinol. 2009 Jul;30(2):93-105
references.pmid: 19410596
references.citation: EMBO J. 1992 Jun;11(6):2131-8
references.pmid: 1376245
references.citation: J Neuropathol Exp Neurol. 2004 Apr;63(4):287-301
references.pmid: 15099019
references.citation: J Biol Chem. 1992 Aug 5;267(22):15721-8
references.pmid: 1639808
references.citation: Endocrinology. 2008 Oct;149(10):5235-43
references.pmid: 18566123
references.citation: Am J Epidemiol. 1994 Aug 1;140(3):256-61
references.pmid: 8030628
references.citation: FEBS Lett. 1994 Nov 21;355(1):35-40
references.pmid: 7957957
references.citation: J Neurosci. 2005 Aug 3;25(31):7191-8
references.pmid: 16079401
references.citation: Nat Med. 1996 Jul;2(7):783-7
references.pmid: 8673924
references.citation: J Biol Chem. 1986 May 5;261(13):6084-9
references.pmid: 3084478
references.citation: Proc Natl Acad Sci U S A. 1975 May;72(5):1858-62
references.pmid: 1057175
references.citation: J Biol Chem. 1992 May 25;267(15):10897-901
references.pmid: 1587865
references.citation: Physiol Rev. 2004 Apr;84(2):361-84
references.pmid: 15044677
references.citation: J Cell Sci. 2007 Aug 15;120(Pt 16):2935-43
references.pmid: 17666435
references.citation: Lancet. 2005 Dec 17;366(9503):2112-7
references.pmid: 16360788
references.citation: Exp Neurol. 2001 Apr;168(2):402-12
references.pmid: 11259128
references.citation: Brain. 2009 May;132(Pt 5):1324-34
references.pmid: 19321462
references.citation: Am J Public Health. 1998 Sep;88(9):1337-42
references.pmid: 9736873
references.citation: Eur J Neurosci. 2005 Oct;22(8):1942-50
references.pmid: 16262633
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3696-701
references.pmid: 10725345